Driehaus Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,389
| Closed | -$56.2K | – | 389 |
|
|
2023
Q3 | $56.2K | Hold |
1,389
| – | – | ﹤0.01% | 389 |
|
|
2023
Q2 | $148K | Sell |
1,389
-22,909
| -94% | -$2.44M | ﹤0.01% | 377 |
|
|
2023
Q1 | $7.25M | Sell |
24,298
-7,323
| -23% | -$2.19M | 0.1% | 261 |
|
|
2022
Q4 | $10.9M | Buy |
+31,621
| New | +$10.9M | 0.16% | 194 |
|
|
2020
Q4 | – | Sell |
-750
| Closed | -$520K | – | 422 |
|
|
2020
Q3 | $520K | Sell |
750
-16,954
| -96% | -$11.8M | 0.01% | 332 |
|
|
2020
Q2 | $15M | Sell |
17,704
-1,042
| -6% | -$884K | 0.37% | 85 |
|
|
2020
Q1 | $6.7M | Buy |
+18,746
| New | +$6.7M | 0.22% | 116 |
|